Some pharmaceutical companies now have teams that are dedicated to designing enzymes to make drugs more efficiently and with fewer toxic catalysts.
Algumas indústrias farmacêuticas têm equipes para projetar enzimas para fazer drogas mais eficientes e com menos catalisadores tóxicos.